Catalyst Wire Dossier Catalyst Wire Dossier

hV01 oncolytic vaccinia virus

oncolytic vaccinia virus (hV01) · Hangzhou Converd Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hV01 oncolytic vaccinia virus, covering 2025-09-22 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Combination Therapy of Oncolytic Vaccinia Virus (hV01) and PD-1 Inhibitor in Advanced Solid Tumors. [NA]

See pricing